Janux Therapeutics (JANX) had the highest return in April 2024 by a mid-cap US stock, returning 51.5%.
Janux Therapeutics (JANX) had the highest return in April 2024 by a mid-cap US stock, returning 51.5%.
Mid-cap stocks are treated as having a market cap between $2B and $10B.